Page 3 - Amrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amrx Today - Breaking & Trending Today

Knight Therapeutics Inks License Agreement With Amneal Pharma For IPX203

Specialty pharmaceutical company Knight Therapeutics Inc. (GUD.TO) announced Thursday it has entered into an exclusive license agreement with Amneal Pharmaceuticals, Inc. ....

Humana Inc , Aviation Administration , Nokia Corp , Medicare Advantage , Federal Aviation Administration , Amneal Pharmaceuticals , Knight Therapeutics , Px203 , Hud To ,

StockNews.com Begins Coverage on Amneal Pharmaceuticals (NASDAQ:AMRX)

StockNews.com assumed coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a research note published on Wednesday morning. The firm issued a buy rating on the stock. Separately, Truist Financial boosted their target price on Amneal Pharmaceuticals from $6.00 to $7.00 and gave the stock a buy rating in a research note on […] ....

Amneal Pharmaceuticals Company Profile , Millennium Management , Amneal Pharmaceuticals , News Ratings For Amneal Pharmaceuticals Daily , Blackrock Inc , Vanguard Group Inc , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Stock Performance , Analyst Recommendations For Amneal Pharmaceuticals , Morgan Stanley , Free Report , Truist Financial , Moderate Buy , Get Free Report , Rubric Capital Management , Capital Management , Amneal Pharmaceuticals Daily , Nasdaq Amrx , Initiated Coverage , Stocknews Com ,

Amneal Pharmaceuticals (NASDAQ:AMRX) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a research note issued to investors on Tuesday morning. The brokerage issued a buy rating on the stock. Separately, Truist Financial upped their price objective on shares of Amneal Pharmaceuticals from $6.00 to $7.00 and gave the company a buy rating in […] ....

Millennium Management , Analyst Recommendations For Amneal Pharmaceuticals , Institutional Trading Of Amneal Pharmaceuticals , Amneal Pharmaceuticals , Vanguard Group Inc , Amneal Pharmaceuticals Stock , Amneal Pharmaceuticals Inc , Blackrock Inc , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Company Profile , Morgan Stanley , Free Report , Truist Financial , Moderate Buy , Get Free Report , Rubric Capital Management , Capital Management , Amneal Pharmaceuticals Daily , Nasdaq Amrx , Initiated Coverage , Stocknews Com ,